Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial

Conclusion
For cirrhotic patients, the revaccination of non-responders to the first three dose cycle, with three additional 40 µg doses, achieved significantly better response rates to those obtained with an isolated 40 µg booster dose.

Trial registration number
NCT01884415.

Source: Gut - December 7, 2023 Category: Gastroenterology Authors: Giraldez-Gallego, A., Rodriguez-Seguel, E. d. P., Valencia-Martin, R., Morillo-Garcia, A., Salamanca-Rivera, C., Ruiz-Perez, R., Cuaresma-Duque, M., Rosso-Fernandez, C., Ferrer-Rios, M. T., Sousa-Martin, J. M., Praena-Fernandez, J. M., Desongles-Corrales, Tags: Gut Hepatology Source Type: research